<DOC>
	<DOCNO>NCT01948128</DOCNO>
	<brief_summary>This protocol randomize , phase 2 `` window opportunity '' trial assess biological effect short term oral vitamin D administration breast cancer clinical translational marker patient await surgery Ottawa Hospital . It take advantage current wait time ( 2-8 week ) breast cancer surgery `` window opportunity '' rapidly assess biological change vitamin D intake .</brief_summary>
	<brief_title>Effects Vitamin D Patients With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . Histologically confirm female primary breast cancer patient whose surgery plan next 28 week without neoadjuvant therapy assess multidisciplinary team 2 . Age ≥18 year 3 . Clinically palpable tumour ( ) ( great equal 2 cm ) 4 . Normal serum urine calcium serum PTH value baseline ( define Ottawa Hospital ) 5 . Written inform consent study 1 . Patients recurrent metastatic breast cancer 2 . History neoadjuvant hormonal therapy , chemotherapy , radiation therapy last 6 month breast cancer cancer treatment 3 . ECOG performance Status &gt; 2 4 . Hypercalciuria initial baseline urine , define Ca/Creatinine Ratio &gt; 1.0 5 . Current previous history urolithiasis hyperparathyroidism 6 . Abnormal hepatic function accord Ottawa Hospital norm ( Total Bilirubin &gt; 2x upper limit normal , ALT/AST &gt; 3x upper limit normal ) and/or abnormal renal function ( Creatinine &gt; 150 µmol/L ) 7 . History granulomatous disease tuberculosis sarcoidosis . 8 . Intake Vitamin D ( cholecalciferol ) supplement ≥ 2000 IU/day within last 2 month 9 . Inability comply study protocol opinion investigator ( abuse alcohol , drug psychotic state ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Breast</keyword>
</DOC>